Artificial lymphoid tissue equivalent
US8030070B2 · kind B2 · utility
3Cited by
12References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2006 |
| Grant date | Oct 4, 2011 |
| Priority date | — |
| Expiry date | Apr 23, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2535/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.